Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06784323 · ClinicalTrials.gov registry record · NA

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

A NA study of Ulcerative Colitis, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
122
Enrollment target
1
Study location

NCT06784323 is a NA study of Ulcerative Colitis that is actively recruiting participants, run by University of Miami. The registered enrollment target is 122 participants, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06784323, a NA study of Ulcerative Colitis, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
122 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

Conditions Studied

Interventions

  • BEHAVIORAL Catered diet
  • BEHAVIORAL Diet guidance sessions
  • BEHAVIORAL Dietary counseling
  • BEHAVIORAL Feedback sessions

Study Locations (1)

Florida

  • University of Miami Health System - Miami

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2025-03-05
Est. Completion 2030-09-01
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06784323

The ClinicalTrials.gov registry entry for NCT06784323 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,056-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (94% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 4 interventions - of which Catered diet is the first listed.

NCT06784323 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06784323 about?

NCT06784323 is a clinical study titled "Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)". The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

What is the current status of trial NCT06784323?

This trial is currently recruiting. It is a NA study. The enrollment target is 122 participants. The study started on 2025-03-05. Estimated completion is 2030-09-01.

What conditions does trial NCT06784323 study?

This clinical trial studies the following conditions: Ulcerative Colitis.

What interventions are being tested in trial NCT06784323?

The interventions under investigation include: Catered diet (BEHAVIORAL), Diet guidance sessions (BEHAVIORAL), Dietary counseling (BEHAVIORAL), Feedback sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06784323?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06784323 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.